SCHEMBL7927697

SCHEMBL7927697

CCCCC(Oc1cc2ccc(-c3ccc(C(=O)O)cc3)cc2cc1C12CC3CC(CC(C3)C1)C2)C(=O)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
THRB P10828 1/20 0.55
RECQL P46063 1/20 0.55
NR2E1 Q9Y466 1/20 0.55
RARB P10826 11/20 0.52
RARG P13631 11/20 0.52
RARA P10276 10/20 0.52
NR1I2 O75469 1/20 0.52
LMNA P02545 1/20 0.52
PGR P06401 1/20 0.52
HSPD1 P10809 1/20 0.52
GOT1 P17174 1/20 0.52
GLRA1 P23415 1/20 0.52
BLM P54132 1/20 0.52
HSPE1 P61604 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7926529 0.95 MEN1 (0.56) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7929483 0.92 MEN1 (0.57) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7927805 0.91 MEN1 (0.56) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7920758 0.88 RARB (0.42) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7927698 0.88 MEN1 (0.58) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7920661 0.87 MEN1 (0.59) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7920636 0.85 MEN1 (0.57) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL9010867 0.85 MEN1 (0.55) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7926552 0.84 MEN1 (0.56) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7927684 0.84 MEN1 (0.56) MEN1KMT2ATHRBRECQLNR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP disclosed